The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
There is current debate concerning the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs), for hypertension management, during COVID-19 infection. Specifically, the suggestion has been made that ACE inhibitors or ARBs could theoretically contribute to infection via increasing ACE2 receptor expression and hence increase viral load. The ACE2 receptor is responsible for binding the SAR-CoV2 viral spike and causing COVID-19 infection. What makes the argument somewhat obtuse for ACE inhibitors or ARBs is that ACE2 receptor expression can be increased by compounds that activate or increase the expression of SIRT1. Henceforth common dietary interventions, vitamins and nutrients may directly or indirectly influence the cellular expression of the ACE2 receptor. There are many common compounds that can increase the expression of the ACE2 receptor including Vitamin C, Metformin, Resveratrol, Vitamin B3 and Vitamin D. It is important to acknowledge that down-regulation or blocking the cellular ACE2 receptor will likely be pro-inflammatory and may contribute to end organ pathology and mortality in COVID-19. In conclusion from the perspective of the ACE2 receptor, COVID-19 prevention and treatment are distinctly different. This letter reflects on this current debate and suggests angiotensin-converting enzyme inhibitors and ARBs are likely beneficial during COVID-19 infection for hypertensive and normotensive patients.
Abstract
There is current debate concerning the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs), for hypertension management, during COVID-19 infection. Specifically, the suggestion has been made that ACE inhibitors or ARBs could theoretically contribute to infection via increasing ACE2 receptor expression and hence increase viral load. The ACE2 receptor is responsible for binding the SAR-CoV2 viral spike and causing COVID-19 infection. What makes the argument somewhat obtuse for ACE inhibitors or ARBs is that ACE2 receptor expression can be increased by compounds that activate or increase the expression of SIRT1. Henceforth common dietary interventions, vitamins and nutrients may directly or indirectly influence the cellular expression of the ACE2 receptor. There are many common compounds that can increase the expression of the ACE2 receptor including Vitamin C, Metformin, Resveratrol, Vitamin B3 and Vitamin D. It is important to acknowledge that down-regulation or blocking the cellular ACE2 receptor will likely be pro-inflammatory and may contribute to end organ pathology and mortality in COVID-19. In conclusion from the perspective of the ACE2 receptor, COVID-19 prevention and treatment are distinctly different. This letter reflects on this current debate and suggests angiotensin-converting enzyme inhibitors and ARBs are likely beneficial during COVID-19 infection for hypertensive and normotensive patients.
참고문헌 (23)
- Cao Y, "Comparative genetic analysis of the novel coronavirus(2019-nCoV", SARS-CoV-2)receptor ACE2 in different populations, 2020, pp.6, 11~
- Muthiah Vaduganathan, "Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19", New England Journal of Medicine, 382(17), pp.1653~1659 (2020), Massachusetts Medical Society[DOI]
- Chen J, "Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation", 2020030191~ (2020)
- Rami Sommerstein, "Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors", Angiotensin Receptor Blockers Have a Biphasic Effect?, 2020, pp.9(7), e016509~[DOI]
- Haibo Zhang, "Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target", Intensive Care Medicine, 46(4), pp.586~590 (2020), Springer Science and Business Media LLC[DOI]
- Vanessa Monteil, "Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2", Cell, 181(4), pp.905~913.e7 (2020), Elsevier BV[DOI]
- Sun ML, "Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia", Zhonghua Jie He He Hu Xi Za Zhi, 43(3), pp.219~222 (2020)[DOI]
- Hao Cheng, "Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19", Journal of Medical Virology, 92(7), pp.726~730 (2020), Wiley[DOI]
- Glowacka I, "Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63", J Virol, 84(2), pp.1198~1205 (2010)[DOI]
- Lei Fang, "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?", The Lancet Respiratory Medicine, 8(4), pp.e21~ (2020), Elsevier BV[DOI]
- Gonzalez AA, "Potassium intakes prevents the induction of the Renin Angiotensin System and increases medullary ACE1 and COX-2 in the kidneys of Angiotensin II dependent hypertensive rats", Front Pharmacol, 10, pp.1212~ (2019)
- Firuzeh Badreh, "Restoration of the Renin–Angiotensin System Balance Is a Part of the Effect of Fasting on Cardiovascular Rejuvenation: Role of Age and Fasting Models", Rejuvenation Research, 23(4), pp.302~312 (2020), Mary Ann Liebert Inc[DOI]
- James L. Olds, "Is nicotine exposure linked to cardiopulmonary vulnerability to COVID‐19 in the general population?", The FEBS Journal, 287(17), pp.3651~3655 (2020), Wiley[DOI]
- Xu J, "Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the reninangiotensin system", Mol Med Rep, 16(5), pp.7432~7438 (2017)
- Clarke NE, "Turner AJ epigenetic regulation of angiotensin-converting enzyme 2(ACE2)by SIRT1 under conditions of cell energy stress", Clin Sci(Lond), 126(7), pp.507~516 (2014)
- Patel VB, "Role of the ACE2", Angiotensin 1–7axis of the renin-angiotensin system in heart failure, 2016, pp.118(8), 1313~1326
- Yu W, "Moderate calorie restriction attenuates age-associated alterations and improves cardiac function by increasing SIRT1 and SIRT3 expression", Mol Med Rep, 18(4), pp.4087~4094 (2018)
- Kim EN, "The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system", Atherosclerosis, 270, pp.123~131 (2018)
- Borra MT, "Mechanism of human SIRT1 activation by resveratrol", J Biol Chem, 280(17), pp.17187~17195 (2005)
- Aşcı H, "Protective effects of aspirin and vitamin C against corn syrup consumptioninduced cardiac damage through sirtuin-1 and HIF-1α pathway", Anatol J Cardiol, 16(9), pp.648~654 (2016)
- Qi MZ, "Intravenous Vitamin C attenuates hemorrhagic shock-related renal injury through the induction of SIRT1 in rats", Biochem Biophys Res Commun, 501(2), pp.358~364 (2018)
- Cuyàs E, "Metformin is a direct SIRT1-activating compound : computational modeling and experimental validation", Front Endocrinol, 9, pp.657~ (2018)
- Hong G, "Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis", Free Radic Biol Med, 123, pp.125~137 (2018)